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Background: Bitter gourd has various metabolites, such as momordicosides, polypeptide-P, v-insulin, charantin, and vicine 
that have antidiabetic effect. It has synergistically effect while combined with oral diabetic drugs, such as metformin as 
glucose lowering agent. The aim of this study is to investigate the interaction of bitter gourd fruit juice and metformin as 
glucose lowering agent in mice.
Materials and Methods: Alloxan-induced diabetic mice were treated with bitter gourd fruit juice, metformin, and the 
combination of those two for 21 days. Glucose level was checked on first and last day of treatment.
Results: Furthermore, blood glucose levels measurement showed no significant difference between groups compared 
with negative control, which was p>0.05. The stomach of groups that treated with metformin and bitter gourd fruit juice 
histopathologically showed no significant differences. 
Conclusion: The use of bitter gourd once daily together with metformin is a better choice, while twice daily might induce 
hypoglycemia and mice death. There is no interaction between them on lowering blood glucose.
Keywords: metformin, Momordica charantia, diabetes mellitus
MCBS
Mol Cell Biomed Sci. 2019; 3(2): 81-7
DOI: 10.21705/mcbs.v3i2.47
C e l l  a n d 
B i o p h a r m a c e u t i c a l 
I n s t i t u t e
Date of submission: December 11, 2018
Last Revised: March 4, 2019
Accepted for publication: March 4, 2019
Corresponding Author: 
Asri Dwi Endah Dewi Pramesthi
Research and Development FARMAKA TROPIS Laboratory 
Faculty of Pharmacy, Universitas Mulawarman 
Jl. Kuaro, Gunung Kelua, Samarinda, Indonesia
E-mail: pramesthiasri@gmail.com
Introduction
Drug and food or drug and traditional medicine interaction 
that mostly happens in patients who receive antidiabetic 
therapy might impacting the effect of therapy. One of them 
is the interaction between metformin and bitter gourd fruit 
juice. Bitter gourd has so many metabolites such as vicine, 
charantin, glycosides and caravylosides. Saponins that 
contained in bitter gourd, like steroid and triterpenoid have a 
good antidiabetic effect.1 Another example of its metabolites 
are momordicosides, momordicilin and momordenol. 
Momordicosides stimulate the translocation of glucose 
transporter 4 (GLUT4) to the cell membrane and enhance 
the uptake of glucose. Momordicilin and momordenol might 
block the active site of glycogen synthase kinase-3 (GSK-
3) and exhibit anti-diabetic activities.2 Metformin and bitter 
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gourd mechanism interaction referred as synergistically 
interaction, because one of three mechanism of metformin 
acts as 5' AMP-activated protein kinase (AMPK)-signalling 
activator, increases insulin receptor sensitivity, and 
stimulates translocation of glucose via GLUT4.3 Small non-
controlled studies have subsequently shown that bitter gourd 
produces a significant improvement in glucose tolerance in 
patients with type 2 diabetes, both when they are taking 
metformin and when they are not taking antidiabetics. In 
these studies, bitter gourd was given orally as a juice from 
the fruit, dried powdered fruit, fried fruits, aqueous extract, 
or solvent extract from the fruit.4
 Metformin is the first biguanides introduced in 
1957 and was approved in 1994. The main mechanism 
of metformin is reduce hepatic glucose production by 
inhibiting gluconeogenesis. It also enhances peripheral 
insulin sensitivity in the skeletal muscle by increasing insulin 
receptor tyrosine kinase activity and GLUT-4 translocation 
to the cell membrane. And then, it could improve beta-cell 
responsiveness to a glucose load through correction of 
glucose toxicity.5
 Based on the mechanism of metformin and bitter 
gourd, there was no study has yet been conducted to 
investigate the interaction between them. The present study 
was conducted to investigate the effect of metformin and 
bitter gourd fruit juice on blood glucose level in mice with 
alloxan-induced diabetes.
Materials and methods
Extraction
Bitter gourd was purchased from the local market at Sungai 
Kunjang, Samarinda, East Borneo, Indonesia. It was used 
with the prior approval of Forest Dendrology and Ecology 
Laboratory, Faculty of Forestry, Universitas Mulawarman 
(No. 27/UNI7.4.3.08/LL/2018). Twenty grams of bitter 
gourds were washed until cleaned thoroughly and the 
excess water was dab-dries with a towel before weighing. 
It was placed in a heat-resist container then was added by 
100 mL aquadest, and cooked in a high power microwave 
for 5 minutes. The cooked bitter gourd and remaining liquid 
were cooled rapidly on the refrigerator to prevent further 
cooking from residual heat and then homogenized with a 
blender. The homogenate was filtered by strainer and the 
liquid was given to the mice.6 The juice was given based 
on mice’s body weight and its stomach capacity, while the 
concentration was 77.58 g/mL.
Laboratory Animals
In this experimental study, 30 male DDY mice weighing 20-
40 g were purchased from LPPT Gadjah Mada University, 
Jogjakarta, Indonesia, and maintained under appropriate 
laboratory conditions with free access to similar ad libitum 
and water. Mice were used with the prior approval of the 
Animal Ethics Committee, Faculty of Medicine, Universitas 
Mulawarman  (No. 27/KEPK-FK/VII/2018).
Diabetes Induction and Animal Grouping
Thirty mice were randomly selected and 5 of them were 
separated as control group or normal group. The other 
mice were induced by Alloxan 180 mg/kg in NaCl 0.9%, 
7 times in 14 days. Before measuring the blood glucose, 
mice were fasted for about 2-3 hours. The blood glucose 
was measured by taking from using tail puncture method 
on the first day of induction, and then checked by using 
glucometer (Autocheck Multi Monitoring System 3 in 1 
Meter, SN AH03011149). After induction and confirmation 
of diabetes, 25 mice were divided into 5 groups consist of 
5 mice each group. Normal group, positive control group 
(metformin), negative control group, bitter gourd group, 
bitter gourd + metformin once daily group (MBG), and 
last group was bitter gourd + metformin twice daily group 
(MBG 2). All administrations were conducted by gavage 
and at a specific time of the day.
Data Analysis
The data distribution was measured using Shapiro-Wilk 
test in SPSS. All variables were met the normal distribution 
assumption in each group, so the ANOVA test was used to 
compare the variables between groups and Bonferroni and 
Games-Howell test was used for multiple comparisons. 
Statistical analysis was done by SPSS ver.22 with the 
significancy level p<0.05.
Results
In this investigation, the alloxan-induced diabetes in 25 
mice. It was divided into five groups beside the normal 
group. Body weight of each group were fluctuated, where 
the highest body weight was measured in metformin and 
bitter gourd group, while the lowest one was seen in positive 
control groups that was treated with metformin. The body 
weight of each group seems fluctuated as seen in Figure 1. 
The negative control group showed the highest weight was 
on day 15 and the lowest one was in day 12. The bitter gourd 
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Figure 1. Average body weight of mice was measured in treatment days.
group showed almost static in body weight changed while 
treatment days. 
 Blood glucose level have decreased from before and 
after treatment. The highest to the lowest blood glucose level 
that was measured before the treatment was the negative 
control group, followed by bitter gourd group, MBG group, 
positive control group, then normal group. While after the 
treatment each group showed decreases in blood glucose 
levels as shown in Figure 2 and Table 1.
 MBG 2 group, which was treated with metformin 
combined with bitter gourd twice daily could decrease blood 
glucose level significantly compared to other groups. Blood 
glucose level was measured before and 30 minutes after 
treatment were performed orally in day 4. Mice number 1, 
2, and 5 show a decrease in blood glucose level after 30 
minutes. The result can be seen in Table 2.
 Compared to normal groups, each group organs had 
increased. Organ index number of spleen and stomach 
was increased significantly compared to other organs. 
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Figure 2. Blood glucose level before 
and after treatment.
Significancy of organ indexes of stomach and spleen were 
both p<0.05. The number of increasing in organ index of 
mice’s organs can be seen in Table 3.
 Data was distributed normally after test of normality 
was performed with there were no significant differences 
between each group (p>0.05) then ANOVA was performed. 
Since then negative control, positive control, bitter groud and 
MBG groups showed there were no significant differences 
(p>0.05) between groups.
 Histopathological observations show in Figure 3. 
In the negative control group’s stomach was found two 
locations of large ulcer with corneum epithelium and keratin 
cell were thickened. It was also shown that there was much 
debris while vascularization congested but the form of the 
gastric pit was normal. Positive control that is treated with 
metformin, the black arrow shows the location of focal 
hyperplasia with epithelium proliferation. The green arrow 
shows the width of ulcer that formed after treatment. In the 
bitter gourd group, the inflammation of cell infiltration was 
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Table 1. Average±standard deviation of blood glucose level 
before and after treatment were performed.
Before After
Control (+) 263.3±94.87 184.3±62.13
Control (-) 340±220.60 150±36.72
Bitter Gourd 297±31.11 261.5±60.10
Bitter Gourd + Metformin 277.75±113.73 205.5±50.44
Group
Average±Standard Deviation of 
Blood Glucose Level (mg/dL)
Before Treatment After 30 Minutes
1 403 321
2 Xi 573
3 482 542
4 156 156
5 426 311
MBG 2 
Mice
Blood Glucose Level (mg/dL)
Table 2. Blood glucose level of MBG 2 group before and 
after 30 minutes of treatment in treatments day 4.
Liver Stomach Spleen Kidney
Normal 4.697±0.44 - 0.360±0.09 0.938±0.29
Control (+) 5.721±1.43 0.839±0.38 0.803±0.33 1.287±0.37
Control (-) 5.637±0.66 1.3675±0.27 0.793±0.19 1.408±0.25
Bitter Gourd 5.164±0.06 1.009±0.23 0.67±0.04 1.364±0.02
Bitter Gourd + Metformin 5.665±0.54 1.907±0.35 0.897±0.19 1.426±0.10
Significancy 0.397 0.005 0.027 0.274
Groups
Average±Standar Deviation (%)
Table 3. Average±standard deviation of organ indexes of each group after treated for 
21 days.
found, with one focal hyperplasia and small keratinization 
was formed. The gastric pit with complete severe erosion 
and increasing of parietal cell is occurred in MBG group. 
There was one focal hyperplasia shows with thickened 
keratinization. There are two locations of focal hyperplasia 
with hyperkeratosis and gastric pit form was considered to 
normal in the stomach of the normal group. 
Discussion
Body weight of each group are fluctuated during treatment 
days. MBG group shows the highest average body weight in 
the first day of treatment and start decreasing in day 5 until 
8. In day 9 to 21 was fluctuatedly increasing. Bitter groud 
group average body weight is under the MBG group. Which 
is fluctuated around 33-37 g. Negative and positive control 
group are fluctuated slightly similar in body weight average 
number. It is between 32-36 g.
 Metformin is well-known as a treatment for obesity. It 
has been found effective to decrease adiposity and obesity-
associated conditions in both human and animal.7 Metformin 
induces an increase in mitochondrial mass like leptin, which 
is a hormone increasing energy expenditure and suppressing 
appetite.8 Reducing the absorption of carbohydrates from the 
gut, suppressing hepatic glycogenesis and hepatic glucose-6 
phosphate, and inhibiting hepatic gluconeogenesis are other 
actions of metformin that may beneficial for obesity.9 Bitter 
gourd has phenolic compound such as simple phenolic 
acids and flavonoids. It has attenuated in vitro adipogenesis 
by activating AMPK signal pathway in preadipocytes and 
decreasing expression of adipogenesis-related factors and 
hypolipidemic effect and lowers the risk of high fat diet-
induced obesity and reduces serum cholesterol.10 
 Mechanism of both metformin and bitter gourd 
represent its ability to decreasing body weight in treatment 
days. Bioactive compounds of bitter gourd may infect the 
variance of body weight. Suppressing appetite is one of 
the side effects that may happen, so it can influence the 
fluctuated body weight. Body weight of each group were 
fluctuated during treatments day as seen in Figure 1.
 In this study, the combination of bitter gourd and 
metformin as antidiabetic therapy might decrease blood 
glucose level significantly. Blood glucose level was measured 
before and after treatment shows that blood glucose level 
was decreased significantly for each group. The data can be 
seen in Table 1. At first, this study was consist of 6 groups. 
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Figure 3. The stomach histology observation after treated for 21 days based on each group. A: Negative control group; B: Positive 
control; C: Bitter groud; D: Bitter groud + metformin; E: Normal; Black arrow: focal hyperplasia with epithelium proliferation; The green 
arrow: width of ulcer that formed after treatment. (Magnitude of 100x by utilizing of inverted microscope Olympus CKX410)
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One of those group is MBG 2 or MBG that was given twice 
a day. In the first week, mice in those group was died one by 
one. It might  be caused by the metabolites of bitter gourd 
have some interactions with metformin so the blood glucose 
level decreased significantly. Blood glucose level decreased 
in MBG 2 group significantly as seen in Table 2.
 Bitter gourd (Momordica charantia) showed 
significant reduction of blood sugar level immediately 
and after 120 minutes of consuming bitter gourd juice in 
patients with type 2 diabetes mellitus.11 The consumption of 
2.5 g dry bitter gourd (equivalent to 50 g fresh bitter gourd) 
may depict an effective approach to lower elevated blood 
glucose levels in individuals with prediabetes. The glucose-
lowering effect of bitter gourd was found higher among 
participants who started with higher baseline fasting plasma 
glucose levels. As the current study included prediabetic 
participants only, the glucose-lowering effect of bitter gourd 
is expected to be even more pronounced among patients 
with higher glucose levels.12 In diabetic streptozotocin-rats, 
the concentration of plasma insulin significantly increased 
at 4 and 6 hours in both normal and diabetic groups by 
using 10 mg/kg bitter gourd extract.1 Antidiabetics such as 
metformin, chlorpropamide, tolbutamide, glibenclamide 
and glinide, blood-glucose lowering effects can be increased 
by bitter gourd. Hypoglycaemic coma and seizures occurred 
in two young non-diabetic children after they were given 
bitter gourd tea.4
 Based on the mechanism of metformin that has been 
used widely for over 50 years, it has been found to be safe and 
efficacious both as monotherapy and in combination with 
other antidiabetics therapy such as bitter gourd. Previous 
studies reported that bitter gourd had beneficial effects in 
reducing blood glucose level. Based on the blood glucose 
level that been measured, metformin, while combined with 
bitter gourd is safe for once daily intake. Bitter gourd seems 
to have a therapeutic effect on lowering blood glucose as 
effective as metformin does.
 Organ index measurement was performed to support 
the blood glucose level data in mice. Liver, spleen, kidney, 
and stomach indexes were measured in this study. Compared 
to normal group, there were no significant differences 
organs swelling. Kidney indexes also shows no significant 
swollen. The therapy that was done in this study did not 
affect the liver and kidney of the mice. It can conclude that 
the combination of metformin and bitter gourd have no 
side effects to those organs. While the spleen of each group 
swells 2-3 times higher than the normal one. The spleens 
from each group show significantly difference (p<0.05). 
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The differences between groups show that stomachs are 
significantly different (p<0.05).
 Bitter gourd has polysaccharides possess 
immunomodulatory effects both in vitro and in vivo. Other 
study said that the immunity enhancement of bitter gourd 
polysaccharides has strong immune-enhancing activity 
and may improve the immune function by stimulating 
the activation of lymphocytes and macrophages.13 The 
mammalian spleen is a peripheral lymphoid organ that plays 
a central role in host defense. The spleen cells proliferated 
to produce the cytokines as an effort to block the immune 
reactivity. The T regulators are produced in this organ as 
immune homeostasis.14,15
 Differences between each groups’ spleen indicate that 
the immune-regulation imbalance resulted from the bitter 
groud effect is processed to be conquered by the spleen 
function. Another difference is seen in the stomach. The 
basic properties of bitter gourd’s metabolites may affect 
gastric pit of mice. The clear differences between groups 
treatment also occurred in the stomach histology.
 Metformin has side effects, notably gastrointestinal 
complaints.16 The most frequent side effect of metformin are 
gastrointestinal disturbance, such as flatulence, abdominal 
pain and loss of appetite.8 Histopathological observation 
used to investigate side effect of metformin and bitter 
gourd. It is shown that negative control was found two 
locations of the wide ulcer with thickening of corneum 
epithelium and hyperkeratinization. It also shown much 
debris with vascularization look congested with hyperemia 
and gastric pit seems normal. In positive control that 
was treated with metformin shown that gastric pit seems 
normal, focal hyperplasia occurred with epithelium erosion 
up to stomach’s lumens with cell debris. In bitter groud 
groups there was one location of smaller focal hyperplasia 
compared to the previous groups with keratinization and 
there were some debris and cell infiltration. MBG group 
shows the complete severe erosion that makes the gastric 
pit looks shorter and diffused. It also shows one hyperplasia 
with large keratinization. There is increasing in the parietal 
cell that makes increasing in HCl production. While in the 
normal group there were two locations of focal hyperplasia 
with hyperkeratosis and gastric pit form was considered to 
normal. 
 Glandular stomach lesions are quite rare in National 
Toxicology Program (NTP) mouse studies. Hyperplasia of 
the glandular stomach mucosa is not common in controls 
but may be seen in regenerative hyperplasias, such as at 
the margin of an ulcer erosion. Glandular hyperplasia is 
characterized by an increase in density of glands within the 
mucosa. In rats, hyperplasia may be a preneoplastic lesion. 
Focal hyperplasia is seen occasionally in mice. However, in 
mice, this is not considered to be a preneoplastic change. The 
incidence is not increased in studies with adenocarcinomas 
of the glandular stomach, and progression from focal 
hyperplasia to adenocarcinoma has not been observed.17 
 Bitter gourd has secondary metabolites that most of 
them have basic properties. The basic properties of bitter 
gourd may affect the gastric pit. Focal hyperplasia in 
normal mice is considered to be normal. MBG group shows 
the complete severe erosion caused by the properties of 
metformin and bitter gourd itself.
Conclusion
Metformin and bitter gourd consumed once daily is 
considered to be safe as antidiabetic therapy. There is no 
interaction while metformin and bitter gourd consumed 
once daily, but the interaction occurred in twice daily dose 
of bitter gourd. It can be lowering the blood glucose level 
of mice and induce hypoglycemia. Bitter gourd juice with 
concentration 77.58 g/mL could reduce blood glucose level 
as metformin does. Histophatology observation shown 
the interaction affect the most in MBG group. Therefore, 
further research to find the real mechanism of bitter gourd 
compounds on diabetes mellitus pathophysiology is 
necessary.
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